Spasmolytic Polypeptide-Expressing Metaplasia and Intestinal Metaplasia: Time for Reevaluation of Metaplasias and the Origins of Gastric Cancer

Gastroenterology

Volumn 138, Issue 7, 2010, Pages

  Goldenring, James R ^a   Nam, Ki Taek ^a   Wang, Timothy C ^b   Mills, Jason C ^c   Wright, Nicholas A ^d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NewYork Presbyterian Hospital   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTESTINAL TREFOIL FACTOR;

ATROPHY; CARCINOGENESIS; DISEASE COURSE; EDITORIAL; HISTOPATHOLOGY; HUMAN; INTESTINE METAPLASIA; METAPLASIA; NONHUMAN; PATHOPHYSIOLOGY; PRECANCER; PRIORITY JOURNAL; SPASMOLYTIC POLYPEPTIDE EXPRESSING METAPLASIA; STOMACH CANCER; STOMACH DISEASE;

EID: 77952737959     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.04.023     Document Type: Editorial

References (5)

1. Correa P. A human model of gastric carcinogenesis. Cancer Res 48 (1988) 3554-3560
2. Rokkas T., Filipe M.I., and Sladen G.E. Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up. Gut 32 (1991) 1110-1113
3. Zivny J., Wang T.C., Yantiss R., et al. 2003 Role of therapy or monitoring in preventing progression to gastric cancer. J Clin Gastroenterol 36 (2003) S50-S60
4. Schmidt P.H., Lee J.R., Joshi V., et al. Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma. Lab Invest 79 (1999) 639-646
5. Lax I., Bellot F., Honegger A., et al. Functional analysis of the ligand binding site of EGF-receptor utilizing chimeric chicken/human receptor molecules. EMBO J 8 (1989) 421-427